- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
Юридические практики
Хотели бы Вы видеть информацию на других страницах на русском языке?
См. страницыРусский - Russian
Наши специалисты
Офисы
Related Lawyers
Закрыть
Recognition
Ranked Band 5 in Nationwide Banking & Finance
Chambers USA 2020
Ranked Band 1 in Georgia Banking & Finance
Chambers USA 2020
Ranked Band 2 in North Carolina Banking & Finance
Chambers USA 2020
Ranked Tier 4 in UAE Banking & Finance
Legal 500 EMEA 2020
Ranked Tier 2 in Saudi Arabia Banking & Finance
Legal 500 EMEA 2020
"They are responsive, know the market and play against the best in the US representing the other side of the table"
Chambers USA 2020
"They are very user-friendly," says another, adding that the firm has a "deep sense of what we focus on and care about."
Chambers USA 2020
A market source says this is an "excellent firm and practice."
Chambers USA 2020
"Commercial, great negotiators, highly responsive and thorough."
Chambers USA 2020
Clients highlight the group's ability to provide "very individualized and very specific attention from senior partners."
Chambers USA 2020
"They are very user-friendly, very accessible and we are very pleased with their work."
Chambers USA 2020
"The firm is commercial with clients and when we have a new deal, they quickly get up to speed."
Chambers USA 2020
Peers note that the firm "dominates the market in terms of size and expertise."
Chambers USA 2020
19 Global Finance lawyers earned individual recognition
CHAMBERS GUIDES 2019
"They've been excellent - they have their finger on the pulse of the marketplace and help us understand the critical points we should be looking at. As far as client interaction goes, they are very commercial and pro-business."
Chamber USA 2019
"They're always willing to go above and beyond to help their client."
Chambers USA 2019
“They were very knowledgeable and responsive, and provided the appropriate advice regarding a number of topics."
Chambers USA 2019
"King & Spalding runs at the same speed as us and knows the market cold"
Chambers USA 2019
Fourth U.S. nationwide ranking
Chambers USA 2019